TrialBritish journal of clinical pharmacology2010

Pharmacokinetics, immunogenicity and bioactivity of the therapeutic antibody catumaxomab intraperitoneally administered to cancer patients.

Peter Ruf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.